| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.258 | 57.229 | 63.043 | 61.767 | 55.480 | 47.272 | 61.265 | 69.280 | 60.107 | 58.611 |
| Total Income - EUR | 55.429 | 57.413 | 63.136 | 61.768 | 55.536 | 47.571 | 62.545 | 91.877 | 60.662 | 58.772 |
| Total Expenses - EUR | 29.148 | 37.400 | 32.305 | 36.904 | 42.577 | 30.553 | 30.958 | 55.070 | 28.805 | 33.210 |
| Gross Profit/Loss - EUR | 26.281 | 20.013 | 30.831 | 24.864 | 12.959 | 17.018 | 31.586 | 36.807 | 31.856 | 25.563 |
| Net Profit/Loss - EUR | 24.618 | 18.864 | 30.199 | 24.392 | 12.261 | 16.560 | 30.974 | 36.127 | 31.323 | 23.835 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Morphomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.292 | 15.107 | 10.159 | 6.102 | 5.297 | 6.587 | 5.543 | 26.485 | 22.277 | 18.009 |
| Current Assets | 77.270 | 6.557 | 38.430 | 68.632 | 69.765 | 82.492 | 26.933 | 11.050 | 16.167 | 62.011 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.190 | 2.001 | 516 | 1.425 | 4.684 | 1.923 | 920 | 3.148 | 5.535 | 25.643 |
| Cash | 76.080 | 4.556 | 37.913 | 67.206 | 65.081 | 80.569 | 26.013 | 7.902 | 10.632 | 36.368 |
| Shareholders Funds | 91.989 | 18.945 | 48.823 | 72.319 | 72.686 | 87.868 | 31.181 | 36.201 | 36.210 | 23.907 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 1.691 | 2.733 | 578 | 2.553 | 2.480 | 1.245 | 1.371 | 1.766 | 2.327 | 56.513 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Morphomed S.r.l.